CARDIOCEPT

Serial Number 90833387
606

Registration Progress

Application Filed
Jul 16, 2021
Under Examination
Jul 12, 2022
Approved for Publication
May 17, 2022
Published for Opposition
May 17, 2022
Registered

Trademark Image

CARDIOCEPT

Basic Information

Serial Number
90833387
Filing Date
July 16, 2021
Published for Opposition
May 17, 2022
Abandonment Date
August 14, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 14, 2023
Classes
005

Rights Holder

Navidea Biopharmaceuticals, Inc.

03
Address
4995 Bradenton Avenue, Suite 240
Dublin, OH 43017

Ownership History

Navidea Biopharmaceuticals, Inc.

Original Applicant
03
Dublin, OH

Navidea Biopharmaceuticals, Inc.

Owner at Publication
03
Dublin, OH

Legal Representation

Attorney
Tina Yin Sowatzke

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description
Aug 14, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Aug 14, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 10, 2023 EXT1 S SOU EXTENSION 1 FILED
Jan 10, 2023 EX1G S SOU EXTENSION 1 GRANTED
Jul 12, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 23, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 23, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 17, 2022 PUBO A PUBLISHED FOR OPPOSITION
May 17, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 27, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 11, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 6, 2022 DOCK D ASSIGNED TO EXAMINER
Sep 20, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Radiopharmaceutical imaging and detection agents for diagnosing and monitoring atherosclerosis
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
CARDIO CEPT

Classification

International Classes
005